Publication & Citation Trends
Publications
28 total
Su1348: EFFICACY, SAFETY, AND TOLERABILITY OF SELADELPAR IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS DUE TO PRIMARY BILIARY CHOLANGITIS (PBC); A POOLED ANALYSIS OF PHASE 2 AND PHASE 3 STUDIES
Cited by 0
Semantic Scholar
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial OA
Cited by 287
Semantic Scholar
A phase II, open label, randomized, noncomparative study of eFT508 (tomivosertib) alone or in combination with avelumab in subjects with relapsed/refractory microsatellite stable colorectal cancer (MSS CRC).
Cited by 6
Semantic Scholar
An Open-Label, I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, and Preliminary in with
Cited by 0
Semantic Scholar
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma OA
Cited by 107
Semantic Scholar
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. OA
Cited by 158
Semantic Scholar
An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma
Cited by 3
Semantic Scholar
Virologic Response Rates to Fixed-Dose Combination Ledipasvir/Sofosbuvir for 8 or 12 Weeks With Baseline Viral Load: 2061
Cited by 0
Semantic Scholar
Research Topics
Hepatitis C virus research
(20)
Liver Disease Diagnosis and Treatment
(15)
Hepatitis B Virus Studies
(9)
HIV/AIDS drug development and treatment
(3)
Chronic Lymphocytic Leukemia Research
(3)
Affiliations
Missouri Baptist Medical Center
Research Medical Center
Kansas City Research Institute
Nordic Bioscience (Denmark)
Kansas City VA Medical Center